login
omicron State Food and Drug Administration of China Sinopharm Group Chinese Biology Coxing Company Covid vaccine
04-27
clinic omicron Covid vaccine State Food and Drug Administration of China Chinese Biology
Pfizer Coronavirus paxlovid State Food and Drug Administration of China nmpa
02-13
Amyotrophic lateral sclerosis drugs zolgensma sma State Food and Drug Administration of China Novartis
01-20
Amyotrophic lateral sclerosis drugs zolgensma sma Novartis State Food and Drug Administration of China
Medical health HKEX Bank of China State Food and Drug Administration of China Surgical robots
01-11
Vidicetizumab Urinary tract carcinoma Rongchang Biology State Food and Drug Administration of China her2
01-06
Coronavirus Zhong Nanshan omicron Coronavirus infection fda State Food and Drug Administration of China Biotechnology U.S. Food and Drug Administration Indications Academician Zhong Nanshan
12-24
![Sinopharm and Kexing Aomikron variant new crown vaccines have been approved for clinical trials in China[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)
